Back

Galectin-3 identifies healthy subjects at risk of developing (pre-)diastolic dysfunction

2 September 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 4 - Prevention - Risk assessment Biomarkers ESC Premium Access ESC Congress 2019

About the speaker

Photo
Mrs Carolin Gehlken

Ammerland Clinic, Westerstede (Germany)

13 More presentations in this session

Presentation thumbnail
Doctor R. Hortegal (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Mr N. Busch (Copenhagen, DK)
Abstract
Presentation thumbnail
Doctor A. Siverina (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
Doctor S. Lee (Seoul, KR)
Abstract
Presentation thumbnail
Ms E. Nyman (Umea, SE)
Abstract

Access the full session

Session thumbnail
Poster Session 4 - Prevention - Risk assessment

The Event

Event poster

ESC Congress 2019

2 September 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Galectin 3 : possible tool for early detection of LV diastolic dysfunction in asymptomatic survivors of childhood, adolescent and young adult cancer
20 June 2025
thumbnail
Congress Presentation
Reduction in left atrial reservoir strain is an independent predictor of atrial fibrillation in patients with arterial hypertension and preclinical diastolic disfunction
1 September 2019
thumbnail
Congress Presentation
Proteomic signatures associated with diastolic dysfunction and cardiac remodelling in a general population: insights from the Bialystok PLUS study
29 August 2025
thumbnail
Congress Presentation
Features of relationship between adipokines and markers of myocardial fibrosis with levels of biomarkers of heart failure in epicardial obesity
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources